| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Payment of contingent consideration liabilities | 0 | 0 |
| Cash used in financing activities | -34,300 | -32,300 |
| Effect of exchange rate changes on cash and cash equivalents | 4,400 | 4,700 |
| (decrease) increase in cash and cash equivalents | -37,200 | -17,400 |
| Cash and cash equivalents at beginning of period | 107,700 | - |
| Cash and cash equivalents at end of period | 70,500 | - |
AVANOS MEDICAL, INC. (AVNS)
AVANOS MEDICAL, INC. (AVNS)